# Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)

> **NCT01106833** · PHASE2,PHASE3 · COMPLETED · sponsor: **Medical College of Wisconsin** · enrollment: 151 (actual)

## Conditions studied

- Chronic GVHD

## Interventions

- **DRUG:** Sirolimus + calcineurin inhibitor + prednisone
- **DRUG:** Sirolimus + prednisone

## Key facts

- **NCT ID:** NCT01106833
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2017-02-14
- **Final completion:** 2018-06
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2018-12-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01106833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01106833, "Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01106833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*